M. Franceschin et al. / Tetrahedron Letters 45 (2004) 9015–9020
9019
hydrophobic chromophores with the possibility of fur-
ther use in aqueous solution. Many useful applications
can thus be envisaged, ranging from dyes for micro-
scopic techniques to the quantization of biological mac-
9. (a) Zollinger, H. Color Chemistry, 2nd ed.;VCH: Wein-
heim, 1991;(b) Schlettwein, D.;Wohrle, D.;Kaarmann,
E.;Melville, U. Chem. Mater. 1994, 6, 3;(c) Gvishi, R.;
Reisfeld, R.;Burshtein, Z. Chem. Phys. Lett. 1993, 213,
338.
1
9
romolecules. We are mainly interested in the ability of
these compounds to induce G-quadruplex DNA struc-
tures and thereby inhibit human telomerase: preliminary
results look promising and a deeper study is being car-
ried out in our group. It is worth noting that the syn-
thetic strategies used to obtain these compounds result
in a great versatility: different side chains can be added
to the new coronene moiety, with the possibility of
achieving selectivity towards different G-quadruplex
structures, as has been shown previously for perylene
1
0. 1,7-Dibromoperylene-3,4:9,10-tetracarboxylic dianhydride
1
(
2a): H NMR (200MHz, D SO ): d 10.42 (d, J = 8Hz,
2
4
2
H, aromatic H), 9.75 (s, 2H, aromatic H), 9.53 (d,
J = 8Hz, 2H, aromatic H). The signals of the minor (1,6)
isomer (2b) are mainly superimposed with those reported
for 2a, a part from the doublet centred at 10.34ppm, that
is sufficiently separated from the other signals to be
integrated, giving a ratio between 2a and 2b of 6:1.
C H O Br : calcd C 52.4, H 1.1;found C 51.6, H 1.1.
24
6
6
2
0
1
1. N,N -Bis[2-(1-piperidino)-ethyl]-1,7-dibromoperylene-3,4:
9,10-tetracarboxylic diimide (PIPER-Br,3a): H NMR
1
1
diimides. Moreover, it is possible to add two different
(
8
300MHz, CDCl
.89 (s, 2H, aromatic H), 8.67 (d, J = 8Hz, 2H, aromatic
H), 4.41 (t, J = 7Hz, 4H, Nimidic–CH), 2.8–2.6 (broad,
3
): d 9.44 (d, J = 8Hz, 2H, aromatic H),
kinds of side chains (one type on the imidic nitrogen
atoms and a different one directly linked to the aromatic
moiety), since they are added in two different steps. This
is very interesting since some G-quadruplex structures
have four identical grooves (where the side chains
mainly interact), while others have grooves of different
1
3
1
2H, Npiperidine–CH), 1.8–1.4 (br, 12H, CHpiperidine);
C
NMR APT (200MHz, CDCl ): d 162.14 (C@O), 161.64
3
(C@O), 137.31 (CHar.), 132.17 (Car.), 132.02 (Car.), 129.29
(CHar.), 128.50 (Car.), 127.78 (CHar.), 126.28 (Car.), 122.55
4
(Car.), 122.12 (Car.), 120.18 (Car.), 55.74, 54.24, 37.41,
dimensions. Finally, by means of intermediate com-
pounds (such as 10), it will be possible to obtain asym-
metric compounds.
+
5.48, 23.81. MS (ESI) m/z: 771.10 [(M + 1) ] (calcd for
2
1
38 34 4 4 2
C H N O Br M = 770.09). In this case, all H NMR
signals of the two isomers are superimposed and it is not
possible to obtain the isomeric ratio.
0
1
2. (a)
N,N -Bis[2-(1-piperidino)-ethyl]-1,7-bis(1-piperid-
[PIP-
Acknowledgements
inyl)perylene-3,4:9,10-tetracarboxylic
PIPER(1,7), 4a(I)]: H NMR (200MHz, CDCl
diimide
1
3
): d 9.46
This work was partially supported by FIRB 2001. MS-
ESI measurements have been performed by Dr. Alessan-
(d, J = 8Hz, 2H, aromatic H), 8.33 (s, 2H, aromatic H),
8.30 (d, J = 8Hz, 2H, aromatic H), 4.32 (t, J = 7Hz, 4H,
1
13
dro Dorio; H and C NMR 300MHz spectra by Mr.
Francesco Piccioni. Thanks are due to Dr. Luigi Ros-
setti and Professor Marcella Guiso for helpful discus-
sions and to Mr. Christoph Schultes of the CRUK-
BSG at the School of Pharmacy, University of London,
for help in the final revision of the manuscript.
N
imidic–CH), 3.38 (m, 4H, Car.–Npiperidine–CH), 2.81 (m,
4
H, Car.–Npiperidine–CH), 2.7–2.4 (br, 12H, Npiperidine
–
1
3
CH), 1.8–1.5 (broad, 24H, CHpiperidine); C NMR APT
(
200MHz, CDCl
50.20 (Car.), 134.90 (Car.), 129.36 (Car.), 127.50 (CHar.),
23.70 (Car.), 123.17 (CHar.), 122.64 (CHar.), 122.34 (Car.),
21.85 (Car.), 120.30 (Car.), 55.87, 54.21, 52.27, 37.15,
5.50, 25.21, 23.88, 23.27. MS (ESI) m/z: 779.41 [(M + 1) ]
3
): d 163.05 (C@O), 162.91 (C@O),
1
1
1
2
+
0
(
piperidino)-ethyl]-1,6-bis(1-piperidinyl)perylene-3,4:9,10-
tetracarboxylic diimide [PIP-PIPER(1,6), 4b(I)]:
calcd. for C48
H
54
N
6
O
4
M = 778.42). (b) N,N -Bis[2-(1-
References and notes
1
H
1
. Rossetti, L.;Franceschin, M.;Bianco, A.;Ortaggi, G.;
Savino, M. Bioorg. Med. Chem. Lett. 2002, 12, 2527.
. (a) Han, H.;Cliff, C. L.;Hurley, L. H. Biochemistry 1999,
NMR (200MHz, CDCl ): d 9.63 (d, J = 8Hz, 2H,
aromatic H), 8.53 (d, J = 8Hz, 2H, aromatic H), 8.31 (s,
3
2
2H, aromatic H), 4.30 (m, 4H, Nimidic–CH), 3.29 (m, 4H,
Car.–Npiperidine–CH), 2.79 (m, 4H, Car.–Npiperidine–CH),
2.7–2.4 (broad, 12H, Npiperidine–CH), 1.9–1.5 (br, 24H,
3
8, 6981;(b) Fedoroff, O. Y.;Salazar, M.;Han, H.;
Chemeris, V. V.;Kerwin, S. M.;Hurley, L. H. Biochem-
istry 1998, 37, 12367.
1
3
CHpiperidine); C NMR (200MHz, CDCl ): d 163.23
3
3
. (a) Kerwin, S. M.;Chen, G.;Kern, J. T.;Thomas, P. W.
Bioorg. Med. Chem. Lett. 2002, 12, 447;(b) Kern, J. T.;
Kerwin, S. M. Bioorg. Med. Chem. Lett. 2002, 12, 3395;(c)
Kern, J. T.;Thomas, P. W.;Kerwin, S. M. Biochemistry
(C@O), 163.10, (C@O), 152.76 (ar.), 135.60 (ar.), 131.24
(ar.), 130.21 (ar.), 128.34 (ar.), 127.51 (ar.), 123.26 (ar.),
122.69 (ar.), 122.61 (ar.), 121.85 (ar.), 120.20 (ar.), 119.68
(ar.), 55.91, 54.22, 52.63, 37.24, 37.06, 25.51, 25.28, 23.84,
+
2
002, 41, 11379.
. Neidle, S.;Parkinson, G. N. Curr. Opin. Struct. Biol. 2003,
3, 275.
23.27. MS (ESI) m/z: 779.43 [(M + 1) ] (calcd for
C H N O M = 778.42).
4
4
8
54
6
4
1
13. Bianco, A.;Cavarischia, C.;Guiso, M. Eur. J. Org. Chem.
2004, 2894.
5
6
. De Lange, T. Nature 2002, 21, 532.
0
. (a) Mergny, J. L.;Helene, C. Nat. Med. 1998, 4, 1366;(b)
Sun, D.;Lopez-Guajardo, C. C.;Quada, J.;Hurley, L. H.;
Von Hoff, D. D. Biochemistry 1999, 38, 4037.
14. N,N -Bis[2-(1-piperidino)-ethyl]-1,6-bis(4-orpholinyl)per-
ylene-3,4:9,10-tetracarboxylic
diimide
[MORPHO-
1
PIPER(1,6), 4b(II)]: H NMR (200MHz, CDCl ): d 9.80
3
7
8
. (a) Incles, C. M.;Schultes, C. M.;Neidle, S. Curr. Opin.
Investig. Drugs 2003, 4, 675;(b) Neidle, S.;Parkinson, G.
Nat. Rev. Drug Discov. 2002, 1, 383.
. (a) Rohr, U.;Schlichting, P.;Bohm, A.;Gross, M.;
Meerholz, K.;Brauchle, C.;Mullen, K. Angew. Chem.,
Int. Ed. 1998, 37, 1434;(b) Rohr, U.;Kohl, C.;Mullen,
K.;van de Craats, A.;Warman, J. J. Mater. Chem. 2001,
(d, J = 8Hz, 2H, aromatic H), 8.55 (d, J = 8Hz, 2H,
aromatic H), 8.32 (s, 2H, aromatic H), 4.31 (m, 4H,
Nimidic–CH), 3.87 (m, 8H, CHmorpholine), 3.19 (m, 4H,
CHmorpholine), 3.03 (m, 4H, CHmorpholine), 2.6–2.4 (br, 12H,
1
3
Npiperidine–CH), 1.6–1.3 (br, 12H, CHpiperidine); C NMR
(200MHz, CDCl ): d 162.45 (C@O), 162.41 (C@O),
3
151.07 (ar.), 134.44 (ar.), 130.81 (ar.), 129.68 (ar.),
127.84 (ar.), 127.29 (ar.), 123.35 (ar.), 122.70 (ar.),
1
1, 1789.